NCT05662202Phase 3Completed

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Study sponsor: Biofrontera Inc. · BFRI

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-09-03Actual
Enrollment · participants172Actual
Source updated2026-08-21Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Overall subject complete response rate. After: Measure: Overall Subject Complete Response Rate.

Check registry source

· 1 field changed

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview